Another potential therapeutic approach that lowers blood glucose concentration in T2DM is blocking the action of DPP-4, an enzyme that degrades the hormone incretin, which is secreted into the blood after a meal to stimulate insulin secretion from pancreatic β-cells and to regulate glucose production by the liver [13]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.